bibliographic resource 4253967 [br/4253967]
https://w3id.org/oc/corpus/br/4253967

is a
title
  • A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhibitor, administered weekly in subjects with advanced malignancies
publication date
  • 2013-01-01
contributor
format
identifier
part of